Omada Health
NASDAQ:OMDAMedical - Healthcare Information Services
+$0.13 today
- Market cap
- $817.04M
- Beta
- 2.09
- P/E (TTM)
- -162.6
- EPS (TTM)
- -$0.11
Volume 1.68M
Average 1.07M
OMDA Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Omada HealthNASDAQ: OMDA
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 256.5% from a year ago
Cash & equivalents stood at $211.77M at the end of Q1 FY2026, up 256.5% from a year earlier and down 4.6% from the prior quarter. Over 3 fiscal years it compounded at +9.7% a year.
Context
- Cash & equivalents amounted to 69.9% of total assets at the end of Q1 FY2026, up 27.9 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +256.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 222.04M USD
- Year-over-year change
- +190.7%
- 3-year CAGR
- +9.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 222.04M | +190.7% |
| FY2024 | 2024-12-31 | 76.39M | -33.9% |
| FY2023 | 2023-12-31 | 115.64M | -31.2% |
| FY2022 | 2022-12-31 | 168.12M | — |
Cash & Equivalents vs competitors
How OMDA compares with its peers on the latest reported figures
- OMDA's Mar 2026 cash & equivalents of $211.77M is the 4th highest of the 5 companies compared; the peer median is $445.91M.
- Its year-over-year change of +256.5% is the highest of 5, against a peer median of +0.6%.
- Cash & equivalents amounts to 69.9% of total assets for OMDA, versus a peer median of 30.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $750.74M | -37.1% | -5.2% | 26.7% | |
| Sep 2026 | $605.6M | +75.1% | +69.7% | 17.1% | |
| Jun 2026 | $286.22M | +20.7% | — | 34.6% | |
| Mar 2026 | $211.77M | +256.5% | +9.7% | 69.9% | |
| Mar 2026 | $179.21M | -19.4% | -30.3% | 55.0% | |
| Peer median (excluding OMDA) | $445.91M | +0.6% | -5.2% | 30.7% | |
Competitors are the stored peer set for OMDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Cash & Equivalents | 168.12M | 115.64M | 76.39M | 222.04M |
| Short-term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 11.67M | 16.44M | 23.92M | 34.59M |
| Inventory | 3.54M | 3.61M | 3.3M | 4.49M |
| Other Current Assets | 2.26M | 3.91M | 5.16M | 11.83M |
| Total Current Assets | 188.56M | 142.88M | 113.06M | 272.93M |
| Property, Plant & Equipment (Net) | 6.06M | 5.6M | 6.07M | 7.94M |
| Goodwill | 13.24M | 13.24M | 13.24M | 13.24M |
| Intangible Assets | 8.31M | 6.27M | 4.26M | 2.41M |
| Long-term Investments | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 5.63M | 7.09M | 14.26M | 8.88M |
| Total Non-current Assets | 33.24M | 32.2M | 37.83M | 32.47M |
| Total Assets | 221.8M | 175.08M | 150.89M | 305.41M |
| Account Payables | 4.11M | 3.62M | 4.17M | 10.28M |
| Short-term Debt | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 |
| Deferred Revenue | 13.44M | 14.89M | 19.53M | 25.06M |
| Other Current Liabilities | 9.99M | 15.49M | 21.12M | 40.39M |
| Total Current Liabilities | 34.51M | 43.79M | 53.95M | 75.73M |
| Long-term Debt | 28.9M | 29.38M | 29.77M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.52M | 2.58M | 2.54M | 0 |
| Total Non-current Liabilities | 31.68M | 32.37M | 32.31M | 0 |
| Total Liabilities | 66.19M | 76.16M | 86.26M | 75.73M |
| Common Stock | 21K | 7K | 8K | 58K |
| Retained Earnings | (329.32M) | (396.83M) | (443.97M) | (456.74M) |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Total Equity | 155.61M | 98.92M | 64.63M | 229.68M |
| Total Debt | 30.81M | 30.58M | 30.19M | 0 |
| Net Debt | (137.31M) | (85.06M) | (46.21M) | (222.04M) |
Omada Health
NASDAQ:OMDA
Intrinsic Alpha fair value
Locked
Current Price
$13.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.